A novel study has identified the inflammatory markers IL-1 and IL-6 as potential biomarkers for diagnosis, prognosis and possible treatment targets for concussion.
In this interview, Matthew Hill speaks to us about how endocannabinoids could be a mechanism of comorbidity between inflammatory disease and anxiety.
Research has demonstrated that boosting the immune system could offer a novel treatment modality for Alzheimer’s disease.
Researchers reveal that post-traumatic stress disorder, anxiety and some types of inflammation may be alleviated by cannabis-like drugs.
According to a recent study, an anti-inflammatory drug given to patients in the early stages of a stroke could reduce harmful inflammation.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Doris Doudet to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson’s disease rat model.
Researchers from Japan have revealed a new neural pathway that links stress with organ dysfunction.
This article evaluates the potential role of vascular dysfunction and chronic inflammation in both acute- and chronic-phase traumatic brain injury, and also features studies investigating biomarkers associated with poorer injury outcome.
Researchers have suggested that NF-ƙB-TNFα signaling is the principle origin of obsessive behavioral abnormalities in frontotemporal dementia.
An evaluation of ‘IL4I1 augments CNS remyelination and axonal protection by modulating T-cell driven inflammation’, recently published in Brain.